share_log

中國生物製藥:自願公告 - 1類創新藥羅伐昔替尼片「ROVADICITINIB (TQ05105)」關鍵註冊研究取得陽性結果

SINO BIOPHARM: VOLUNTARY ANNOUNCEMENT - CATEGORY 1 INNOVATIVE DRUG "ROVADICITINIB (TQ05105)" OBTAINED POSITIVE RESULTS IN KEY CLINICAL RESEARCH FOR REGISTRATION

Hong Kong Stock Exchange ·  Apr 18 07:27
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more